Retroviral resistance mediated by the murine Fv1 gene is believed to result from a direct interaction between the Fv1 gene product and the viral capsid protein. To study the mechanism of Fv1 action, the expression and intracellular localisation of the Fv1 protein were examined. Only very low levels of protein expression seem necessary for virus restriction but the site of expression appears crucial. Active Fv1 was found in association with tubules of the trans-Golgi network, whereas an inactive form was localised in the endoplasmic reticulum. We hypothesize that Fv1 is compartmentalised in the cell on the pathway taken by virus en route to the nucleus, suggesting that incoming virus must pass the trans-Golgi network during its transit to the nucleus.
Introduction
Friend virus susceptibility 1 (Fv1) was first described in the 1970s as a gene in mice which conferred resistance to infection with the murine leukemia virus (MLV) (Lilly, 1970) . Mice that carried the Fv1 n allele were susceptible to N-tropic viruses but were resistant to B-tropic viruses (Lilly and Pincus, 1973) . Similarly, mice carrying the Fv1 b allele could be infected by B-tropic viruses but not by N-tropic viruses. NB-tropic viruses are not restricted by either Fv1 n or Fv1 b . As cell lines isolated from the mice retained their ability to restrict viruses, it could be concluded that the resistance to retroviral infection was an innate property of the cells and was not conferred by the murine immune response (Rosenberg and Jolicoeur, 1997) . In vitro, Fv1 restriction was not absolute but reduced viral titres by 50 to 1000-fold (Hartley et al., 1970) .
Fv1 has been cloned and sequenced. Intriguingly, it is homologous to the gag sequence of an endogenous retrovirus (Best et al., 1996) . The Fv1 b allele encodes a protein of 459 amino acids. Fv1 n was found to be 19 amino acids shorter than Fv1 b . The two alleles also differ by two amino acids near the C-terminus of the protein. Fv1 b contains a glutamic acid at position 358 and an arginine at position 399 while Fv1 n contains lysine and valine at the respective positions. Similar to the Gag protein of most retroviruses, Fv1 contains a highly conserved sequence known as the major homology region (MHR) (Bénit et al., 1997) . This region has been shown to be essential for the viability of retroviruses in both the early as well as the late stages of their life cycle (Craven et al., 1995; Mammano et al., 1994; Strambio-de-Castillia and Hunter, 1992) . In Fv1, the integrity of this region is required for function as the introduction of nonconservative sequence changes abolishes its ability to restrict (Bishop et al., 2001) . Analysis of a number of Fv1 deletion mutants suggested the presence of two possible functional domains in the protein, an N-terminal domain and a C-terminal domain that are separated by a flexible linker. This organisation was reminiscent of the structures of the retroviral CA that have been solved (Clish et al., 1998) .
The mechanism by which Fv1 restricts MLV infection remains unknown. Initial studies showed that Fv1 acts at an early stage of the viral life cycle that is postentry but preintegration (Jolicoeur, 1979; Pryciak and Varmus, 1992) . Furthermore, genetic evidence suggests that there might be a direct interaction between Fv1 and CA of MLV (DesGro-seillers and Jolicoeur, 1983; Ou et al., 1983) . A single amino acid difference in position 110 in the MLV CA is sufficient to alter the susceptibility of the virus to each allele of Fv1 (Kozak and Chakraborti, 1996) . In addition, CA has been found to remain associated with the reverse transcription and preintegration complexes that are present in the early stages of the viral life cycle (Fassati and Goff, 1999) .
To facilitate the study of Fv1, antibodies were raised in rabbits (Bishop et al., 2001) . They provide a valuable tool to perform immunohistochemical analyses on the expression of the protein. We hoped that such analyses could provide more information about the manner in which Fv1 restricts retroviruses. Further, it would be reasonable to assume that Fv1 is associated with a compartment of the cell that the incoming subviral particle navigates on its way to the nucleus. Thus, knowledge of the site where Fv1 resides might also provide some insight to the pathway of nuclear translocation by the preintegration complex, which still remains unclear. With these aims in mind, we sought to determine the cellular localisation of Fv1. This article describes the results of these studies.
Results

Natural Fv1 expression levels are low
Our previous studies had suggested that natural levels of Fv1 expression were likely to be low (Best et al., 1996; Bock et al., 2000) . Indeed, preliminary experiments using conventional immunofluorescent methods failed to detect Fv1 (results not shown). To assess the relative levels of natural and transduced Fv1 expression, Western blot analyses were performed on cell lysates from a variety of cells ( Fig. 1 ). Using 350 g of total protein from NIH3T3 and BALB3T3 cells, a band of approximately 50 kDa, corresponding to the predicted size of Fv1, could be detected using an enhanced chemiluminescence detection system (lanes 3 and 4). The band corresponding to Fv1 n (lane 3) was 10 times more intense than Fv1 b (lane 4), suggesting that Fv1 n was expressed at a higher level than Fv1 b , at least in the cell lines examined. By contrast, a band of similar size was detected with 40 g of total protein from cell lysates of Mus dunni cells, a Fv1-null cell line (Lander and Chattopadhyay, 1984) , which had been transduced (m.o.i. ϭ 1) with an MLV-based vector carrying Fv1 n . This band was severalfold more intense than that for NIH3T3 cells, suggesting that Fv1 n is expressed at significantly higher levels from a MLV LTR than the natural promoter.
Correlation between localisation pattern of Fv1 and its function
Given the difficulty of detecting the low natural levels of Fv1 expression in NIH3T3 and BALB3T3 cells, we initially focused on the localisation of Fv1 in cells that express the gene at a higher level from a retroviral promoter. Immunofluorescent staining was performed on M. dunni cells that had been transduced with retroviral vectors carrying Fv1 (m.o.i. ϭ 1). A typical staining pattern for wild-type Fv1 n is shown in Fig. 2A . Fv1 seemed to be localised in punctate structures that were clustered close to the nucleus of the cell. These structures ranged from almost spherical to slightly elongated and some were observed to contain a hollow centre. No staining of the nucleus was observed. A few spots were occasionally seen within the space of the nucleus but these were always found to be in a focal plane that was above the nucleus. The localisation pattern was identical when the cells were fixed with either 4% paraformaldehyde or methanol, showing that the observed distribution was not an artefact of fixation. This pattern was quite similar to the staining of vesicles or mitochondria in the cells (Allan, 2000) . Transduced Fv1 b showed an identical staining pattern (results not shown).
Next, we examined the cellular localisation of a variety of Fv1 mutants, constructed during our previous work on the functional analysis of Fv1 (Bishop et al., 2001) . All of the mutants that retain the ability to restrict showed the wild-type punctate staining pattern. These included neutral MHR substitution mutants and an internal deletion mutant, Int2-5, that was deleted from amino acid 123 to 202 (Bishop et al., 2001 ) (see Fig. 3 ). The staining pattern of the mutants that failed to restrict did not resemble wild type. Two different patterns were observed for the nonrestricting mutants. The first pattern was seen with Int1 ( Fig. 3) , which was a mutant that was deleted from amino acids 109 to 118 in the proximal region of the protein when introduced at an m.o.i. ϭ 1 (Bishop et al., 2001) . It exhibited a staining pattern that was very similar to that shown by the endoplasmic reticulum (data not shown) (Terasaki and Reese, 1992) with a lacy patchwork of staining extending through the cell. At higher multiplicity of transduction (m.o.i. ϭ 5), aggregates of proteins could also be observed near the nucleus in addition to the reticulate staining (Fig. 2B ). The signal from these aggregates was saturated in Fig. 2B as the image had to be overexposed to reveal the reticulate pattern. Lane 1 was loaded with 40 g of protein, while lanes 2-4 were loaded with 350 g of total protein. The bands were detected by enhanced chemiluminescence after probing with an anti-Fv1 antibody used at 1:100 dilution followed by HRP-conjugated protein A. As predicted from the relative gene sizes, the product of the Fv1 b allele shows reduced mobility compared to Fv1 n . Lane 1: The second pattern of staining was seen with mutants that were modified in the C-terminal third of Fv1 (Fig. 3 ). They showed a staining pattern that appeared fibrous, with tubular structures radiating from the nucleus (Fig. 2C ). On longer exposure, a fainter reticulate pattern could also be observed underneath the fibres (Fig. 2D ). The reticulate structure could not be detected at lower exposure as it was much finer and emitted a weaker fluorescence than the fibrous structures. This reticulate pattern was not observed when the image of wild-type Fv1 was overexposed in a similar manner. Mutants with this staining pattern include an internal deletion mutant, Int10, which was deleted from amino acid 374 to 383, and the C-terminal deletion mutants, Fv1 n (delta 411-440) and Fv1 b (delta 411-459) (Bishop et al., 2001) . The MHR-substitution mutants that failed to restrict also showed this pattern of localisation. These observations suggested that the localisation pattern of Fv1 was associated with its ability to restrict. Difference in distribution patterns between Int1 and C-terminal mutants also suggested that the two types of mutants were disrupted in different ways.
Association between Fv1 and the cytoskeleton
Previous reports have documented a variety of interactions between retroviral Gag proteins and the cytoskeleton. These include the assembly and budding of the virus at the cell surface during the late stages of the viral life cycle (Damsky et al., 1977; Edbauer and Naso, 1983; Rey et al., 1996) , as well as the translocation of preintegration complexes towards the nucleus during the early stages of infection (Chicurel, 2000) . Since Fv1 is homologous to a retroviral Gag protein, we wondered if it was also associated with the cytoskeleton. Double-labelled immunofluorescent studies were carried out to determine if Fv1 colocalised with the various components of the cytoskeleton.
The actin filaments were stained with tetramethylrhodamine B isothiocyanate (TRITC)-conjugated phalloidin (Wulf et al., 1979) . There did not seem to be any colocalisation between the actin filaments and Fv1 (Fig. 4A) . The filaments were observed to run across the cell over the nucleus, while Fv1 was found around the nucleus. The microtubules were revealed using an antibody directed against ␤-tubulin (Gozes and Barnstable, 1982). There was some degree of colocalisation between the punctate struc-tures of Fv1 and the microtubule network ( Fig. 4B ). However, this only occurred near the nucleus and not along the length of the microtubules, suggesting that Fv1 might be associated with structures that are attached near the base of the microtubules. The same observation was made when the intermediate filaments were immunostained with antivimentin ( Fig. 4C ). There appeared to be some degree of localisation between the intermediate filaments and Fv1 near the nucleus of the cell.
To confirm the association of Fv1 with microtubules and intermediate filaments, cytoskeleton-disrupting drugs were used to treat Fv1-transduced cells and their effects on Fv1 localisation were observed. Cytochalasin D, which disrupts actin filaments (Miranda et al., 1974) , caused a general collapse of the cell towards the nucleus (Fig. 5B ). However, the punctate, perinuclear distribution of Fv1 was unaffected, confirming the lack of association between Fv1 and actin filaments. Disrupting the cells with acrylamide, which caused the collapse of the intermediate filament network (Eckert, 1985) , resulted in the accumulation of Fv1 to a juxtanuclear position (Fig. 5C ). The position of Fv1 corresponded to the same side of the nucleus as the collapsed intermediate filament network, although there was no absolute colocalisation (results not shown). Treatment of the cells with nocodazole, which depolymerises tubulin (De Brabander et al., 1976) , resulted in the most dramatic redistribution of Fv1. The disruption of microtubules caused the punctate structures of Fv1 to relocate throughout the cell (Fig. 5D ). While they were only perinuclear in untreated cells, nocodazole treatment resulted in the punctate struc- tures being found in the periphery of the cell as well. This response to nocodazole treatment was characteristic of organelles that are attached to microtubules (Cole and Lippincott-Schwartz, 1995) , which include the various components of the endocytic/exocytic pathway such as endosomes, lysosomes, Golgi apparatus, and trans-Golgi network (TGN). Hence, the data strongly suggested that Fv1 is localised in or on a cellular compartment that is associated with microtubules and intermediate filaments.
Association of Fv1 with the trans-Golgi network
In attempts to determine the site of localisation of Fv1 in the cell, specific cellular components were stained with fluorescent dyes in Fv1-transduced cells. Fv1 did not colocalise with mitochondria stained with MitoTracker red (Poot et al., 1996) nor with lysosomes that were stained with Lucifer yellow (Swanson et al., 1987) (results not shown). Staining of the TGN with the dye BODIPY FL C 5 -ceramide (Pagano et al., 1991) revealed a network of tubules that radiated from the nucleus (Fig. 6B ). In addition, a collection of spherical perinuclear vesicles that stained more intensely was also found close to the tubules. Fv1 n did not colocalise with any of the TGN vesicles that were stained by BODIPY FL C 5 -ceramide. However, quite unexpectedly, the punctate structures that contained Fv1 n colocalised with some sections of the TGN tubules ( Fig. 6A-C) . A similar pattern of colocalisation was also observed for Fv1 b .
To confirm the localisation of Fv1, the position of Fv1 in transduced cells was compared to that of TGN38, a transmembrane protein that was known to be resident in the TGN (Luzio et al., 1990) . TGN38 was present in a series of perinuclear tubules (Fig. 6E ). Consistent with the observations with BODIPY FL C 5 -ceramide, Fv1 was located along sections of the tubules where TGN38 was found ( Fig. 6D -F). These results supported the notion that Fv1 was localised to the tubules of the TGN in the transduced cells.
The TGN tubules in M. dunni cells resembled the radi-ating fibrous structures seen in the localisation pattern of the C-terminal mutants of Fv1 that did not restrict. This prompted us to ask if the C-terminal mutants also localised to the TGN tubules. Immunofluorescent staining was performed on M. dunni cells that were transduced with the various C-terminal mutants. These cells were also stained with BODIPY TR-ceramide to reveal the TGN. A typical staining pattern is shown by the MHR mutant, V282E (Bishop et al., 2001) in Fig. 6G -I. As expected, the Fv1positive fibrous structures were found to colocalise with the tubules of the TGN. The same pattern was seen with the other nonrestricting MHR mutants, C-terminal truncation mutants, as well as a mutant containing an internal deletion near the C-terminus. Hence, the C-terminal mutants were associated with the same cellular structures as the wild-type protein. However, unlike the wild-type protein that was only found associated with sections of the TGN tubules, the C-terminal mutants were found along the whole length of the tubules. One possible explanation could be that the wild-type protein was capable of multimerising, thereby forming aggregates at various sites on the tubules. The C-terminal mutants, which were expressed at the same level as the wild-type (Bishop et al., 2001) , might have lost the ability to multimerise/aggregate and therefore remain distributed along the length of the tubule. In contrast, the N-terminal mutant Int1 (Bishop et al., 2001) , which showed a reticulate staining pattern, did not colocalise with the TGN (Fig. 6J-L) . This mutant was deleted from amino acids 109 to 118. On close examination, the tubules of the TGN were found to run through the gaps in the Int1-positive reticulate structure. This structure colocalised with the endoplasmic reticulum, which was stained green with AlexaFluor 488-conjugated concanavalin A (Cottin et al., 1999) (Fig. 7) . Hence, the N-terminal mutant failed to localise in the same areas of the cell as the wildtype protein and the C-terminal mutants. This suggested that a signal required for proper localisation of Fv1 was present in the region of the protein containing amino acids 109 - Fig. 4 . Association of Fv1 with the cytoskeleton. Double-labelled immunofluorescence images stained to examine the association between Fv1 and the various cytoskeletal components in Fv1-transduced (m.o.i. ϭ 1) M. dunni cells. (A) Actin filaments. Fv1 n was stained green using an anti-Fv1 antibody followed by a FITC-conjugated anti-rabbit antibody, while actin filaments were stained red with TRITC-conjugated phalloidin. (B) Microtubules. Fv1 n was stained green using an anti-Fv1 antibody followed by a FITC-conjugated anti-rabbit antibody, while microtubules were stained red with an anti-␤-tubulin antibody followed by a TRITC-conjugated anti-mouse antibody. (C) Intermediate filaments. Fv1 n was stained red using an anti-Fv1 antibody followed by a TRITC-conjugated anti-rabbit antibody, while vimentin filaments were stained green using an antivimentin antibody followed by a FITC-conjugated anti-goat antibody.
118. Taken together, the localisation patterns of the wildtype and mutant proteins were consisten with the notion of a localisation domain in the N-terminal region of Fv1 and a multimerisation/aggregation domain in the C-terminal third.
Localisation of endogenously expressed Fv1
The previous experiments had been performed using Fv1-transduced M. dunni cells, where protein expression was driven by the MLV LTR. This was more than 10-fold higher than endogenous expression. We were therefore concerned that the localisation observed with the transduced protein could be an artefact of overexpression. Hence, it seemed important to determine the localisation of endogenously expressed Fv1. As mentioned previously, it was difficult to detect natural levels of Fv1 using conventional immunostaining techniques. Hence, we sought to amplify the signal using the tyramide signal amplification (TSA) Briefly, a horseradish peroxidase (HRP) conjugated secondary antibody was added during the immunostaining procedure. The HRP catalyses the activation of fluorescent tyramide radicals, which are then covalently coupled to nucleophilic residues that lie close to the HRP-target interaction site.
Using the TSA system, endogenously expressed Fv1 n appeared to be localised to perinuclear membranous structures in NIH3T3 cells (Fig. 8A, top cell) . Although the resolution was lower than conventional immunofluorescent staining, these structures could be seen to be radiating from the nucleus. Occasionally, some staining was observed in the region of the nucleus but these were always found to be in a focal plane that was above the nucleus. When the TGN was revealed using BODIPY TR-ceramide (Ugur and Jones, 2000) , the Fv1 n -containing structures were seen to colocalise with TGN tubules (Fig. 8D ). This was consistent with the data from the studies with transduced cells. However, unlike in the case of transduced cells where Fv1 n was localised in sections of the tubules, endogenously expressed Fv1 seem to be found along the whole length of the tubules. A possible explanation for this observation might be that the levels of endogenously expressed Fv1 n were too low to result in aggregate formation.
M. dunni cells, which are Fv1-null, appeared to show a low level of background signal with the TSA system. This background could be due to nonspecific action of the pri-mary antibody as no signal was detected with the HRPconjugated secondary antibody when the primary antibody was omitted in the staining procedure (results not shown).
However, it was difficult to compare the difference in intensity with the positive signal in NIH3T3 cells when the two cell types were examined on separate coverslips. To rule out the possibility that the localisation pattern in N3T3 cells was an artefact of background staining, GFP-transduced M. dunni cells were seeded with NIH3T3 cells on the same coverslip. The Fv1-negative cells emitted a green fluorescence but had a low background staining with TSA (bottom cell in Fig. 8A and C) . In contrast, the NIH3T3 cells, which are Fv1 n -positive, showed a more intense staining with TSA and did not emit any green fluorescence. This confirmed that the Fv1 localisation pattern observed in NIH3T3 cells was not an artefact of background staining. Furthermore, while the TGN was stained with equal intensity by BODIPY TR-ceramide in both NIH3T3 and GFP-M. dunni cells (Fig. 8B) , the tyramide signal was significantly more intense in NIH3T3 cells (Fig. 8A) . Hence, the localisation pattern was not due to the leaching of TGN signal into the tyramide channel during image capture.
Attempts to visualise natural levels of Fv1 b in BALB3T3 cells were unsuccessful even with signal amplification using TSA. It was unlikely that this was due to poorer recognition by the primary antibody as the anti-Fv1 antibody was a polyclonal antibody generated by immunising with Fv1 n , which shared more than 94% homology with Fv1 b . In light of the results of the Western blot analyses performed on endogenously expressed Fv1, it appears most likely that our inability to detect Fv1 b in BALB3T3 cells can be explained by the significantly lower levels of protein expression.
Fv1 restriction appears independent of the mode of viral entry
The TGN receives cargo from the endocytic pathway as part of the route taken by some internalised receptors on their return to the plasma membrane (Lemmon and Traub, 2000) . As Fv1 was found to localise in the TGN, it was tempting to speculate that following infection, MLV might travel via the endocytic pathway to the TGN where it would then encounter Fv1. Studies of Fv1 restriction had previously been performed with ecotropic viruses (Jolicoeur, 1979) or viruses pseudotyped with vesicular stomatitis virus glycoprotein (VSV-G) (Bock et al., 2000) . In both cases it is believed that the newly infecting virus is internalised via membrane fusion in endosomes (Katen et al., 2001; Kizhatil and Albritton, 1997; Matlin et al., 1982) . To investigate if this route of entry is required for Fv1 restriction, restriction assays were performed on viruses that are thought to enter the cell by direct fusion at the plasma membrane. Two different systems were used in this study. The first involved using MLV particles pseudotyped with the 4070A amphotropic envelope, which has been reported to be pH independent for entry (McClure et al., 1990) and thus have been presumed not to utilize an endosomal pathway (see Discussion). The second system consisted of challenging Fv1transduced XC cells with ecotropic virions, which have been described to enter via direct fusion at the surface of these cells (Kizhatil and Albritton, 1997; McClure et al., 1990) .
The restriction assays were performed as described previously. The results are shown in Fig. 9 . As we have previously shown (Bock et al., 2000) , Fv1 n -transduced M. dunni cells were permissive for N-and NB-tropic viruses pseudotyped with VSV-G but restricted VSV-Gpseudotyped B-tropic viruses. In addition, Fv1 b -transduced M. dunni cells restricted VSV-G-pseudotyped N-and NBtropic viruses but not B-tropic viruses that were pseudotyped with VSV-G. The ability to restrict did not seem to depend on the viral envelope used as Fv1 n -transduced M. dunni cells were also able to restrict B-tropic viruses pseudotyped with the 4070A envelope. Similarly, Fv1 b -transduced M. dunni cells were able to restrict N-and NB-tropic viruses pseudotyped with the 4070A env gene. Further, Fv1-transduced XC cells were also able to restrict viruses containing the ecotropic envelope. Fv1 n -transduced XC cells restricted B-tropic particles, while Fv1 b -transduced XC cells restricted N-and NB-tropic particles. These data imply that Fv1 restriction is not dependent on the mode of entry of viruses into the cytoplasm. Nevertheless, the fact that restriction occurs suggests that the TGN might be a compartment common to both surface and endosomal pathways of viral entry after membrane fusion had taken place.
Discussion
In this study, we have examined the expression of the protein product of the mouse retrovirus restriction gene, Fv1. We have shown (i) that natural levels of Fv1 expression are very low and (ii) the protein is localised primarily in association with tubules of the TGN. We will now consider these findings in the context of our present understanding of the Fv1 gene and its mode of action.
The low levels of protein expression come as little surprise in light of our previous experience with the Fv1 gene. mRNA expression can only be detected by very sensitive nuclease protection or PCR techniques (J.P. Stoye and P. Le Tissier, unpublished data). This is consistent with the structure of the gene, where the inserted gag gene appears to be transcribed from a normal cell promoter but in an antisense direction relative to the promoter, and polyadenylation occurs either via an inserted intracisternal A type particle LTR (Fv1 n allele) or at a B2 repeat (Fv1 b allele) (Best et al., 1996) , (J.P. Stoye and P. Le Tissier, unpublished data). Apparently consistent with the protein expression data, Fv1 mRNA is present at about threefold lower levels in BALB3T3 cells than NIH3T3 cells (Ellis, 2000) . The greater amount of Fv1 found in NIH3T3 cells is also consistent with earlier experiments on the hitness of infectivity, which suggested that Fv1 b restriction in BALB3T3 cells is easier to overcome than Fv1 n restriction in NIH3T3 cells (Benjers et al., 1979) .
The punctate pattern of localisation of overexpressed Fv1 was similar to the localisation pattern observed with several retroviral proteins. MoMLV-␤-gal fusion proteins were observed to localise to compartments that were reminiscent of rough ER-Golgi and numerous microvillus-type structures, although the cellular compartments were not verified by specific organelle markers (Jones et al., 1990) . HIV-1 Gag that was mutated in the N-terminal basic residue cluster in the matrix domain localised near the Golgi and TGN-proximal region (Hermida-Matsumoto and Resh, 2000) . HTLV Gag did not seem to localise to any known membranous cellular compartment, although it showed a punctate cell localisation pattern (Le Blanc et al., 2002) . Having 60% identity to the Gag protein of HERV-L (Best et al., 1996) , it is perhaps not surprising that Fv1 is behaving in a similar manner in cells. In addition, retroviral budding into ER and Golgi has been detected (Hansen et al., 1993) , further supporting the association of Gag with intracellular membranes. However, similar to other retroviral Gag pro-teins, there is an absence of a classical signal peptide in the N-terminus of Fv1. Hence, it is likely that the protein is found on the cytosolic face of the membranes of the TGN and ER. This would be consistent with the annular structures seen in our initial analyses.
There seemed to be a correlation between restriction and the association of Fv1 with the TGN, as the mutant, Int1, which failed to restrict, did not localise to the TGN, although it was found in the ER. The presence of Int1 in the ER also suggested that the localisation signal might comprise two components: one which brought the protein to the ER, while the other allowed it to move to the TGN. The mutant, Int1, might be impaired in the second signal component, resulting in its retention in the ER. Colocalisation of Fv1 with the TGN was necessary but not sufficient for its activity, as there were nonrestricting mutants which were found in the TGN. Unlike wild-type Fv1, these mutants, which were modified in the C-terminal third, were found along the length of the TGN tubules, suggesting that they might lack the ability to multimerise. Although the distribution of these mutants resembled that of endogenous Fv1 n , the failure to form punctate structures that were seen in the wild-type was not due to lower concentrations of the mutant proteins. This was because both wild-type and mutants were expressed from identical retroviral promoters in the transduced cells and had been found to be expressed at similar levels previously (Bishop et al., 2001) . Current co-immunoprecipitation experiments strongly suggest the presence of a multimerisation domain in the C-terminal region of Fv1. Co-immunoprecipitation was not seen with the MHR mutants that failed to restrict (M.W. Yap and J.P. Stoye, unpublished data) and we speculate that Fv1 activity may require multimerisation. Int1 was a mutant that seemed to retain its multimerisation function, although it was unable to localise to the TGN. Hence, it could probably interact with wild-type Fv1. It will be interesting to see if Int1 could abrogate wild-type Fv1 function by preventing it from localising to the correct cellular compartment.
The association of Fv1 with the TGN suggested that incoming viruses passed through this cellular compartment where interaction with Fv1 occurred. The TGN is an organelle involved in the later stages of sorting in the exocytotic pathway (Traub and Kornfeld, 1997) . It also receives cargo from the endocytotic pathway (Lemmon and Traub, 2000) . In particular, some internalised receptors pass through this cellular component following receptor-mediated endocytosis before they are recycled back to the plasma membrane (Straley and Green, 2000; Vandenbulcke et al., 2000; Yamashiro et al., 1984) . Hence, it is conceivable that viruses internalised by endocytosis after binding to their receptors could be transported to the TGN as part of the route taken to the nucleus. Entry into the cytoplasm could take place from this cellular compartment. Alternatively, fusion between the viral and host membrane might take place in the endosomes, after which the virus could remain associated with the endocytic pathway. We found that Fv1 restriction also affected viruses that were previously described to enter at the cell surface, suggesting that these viruses might also pass through the TGN during the infection process. However, recent evidence from studies of avian retrovirus entry indicated that pH independence might not provide a reliable means for discriminating between sites of virus-cell membrane fusion (Mothes et al., 2000) . Hence, we cannot exclude the possibility that MLVs containing Env which are pH-independent for membrane fusion could still enter the cell via the endocytic pathway. An alternative explanation for the restriction of these viruses could be that the actual interaction between Fv1 and the incoming virus might occur elsewhere, although the majority of Fv1 was localized to the TGN. To address this issue, we are currently attempting to label the virus with a fluorophore to follow its pathway in the cell.
Previous studies have not revealed any difference in integration activity measured in vitro using preintegration complexes isolated from Fv1-restricted or nonrestricted cells (Pryciak and Varmus, 1992) . The absence of Fv1 from the nucleus provides further evidence that restriction of viruses occurs prior to integration. Localisation of Fv1 in a cytosolic compartment suggests that restriction takes place before entry of the preintegration complex into the nucleus. Normal levels of nucleus-associated linear DNA have been reported in Fv1-restricted cells, but reduced DNA circles were seen (Pryciak and Varmus, 1992) . It is thus tempting to speculate that a late step in nuclear translocation might be affected. Attempts at labelling the preintegration complex could provide some insight to this possibility.
In conclusion, Fv1 seemed to behave similar to a conventional retroviral protein in terms of its localisation and multimerisation. It might represent a truncated Gag that is impaired in its ability to assemble into viral particles but retains the features allowing it to form multimers that associate with the TGN. The multimeric form of Fv1 might interact with incoming MLV in this cellular compartment. Work is currently ongoing to study the nature of the interaction between Fv1 and MLV CA.
Materials and methods
Recombinant DNA
Fv1 and its mutants were introduced into M. dunni cells by transduction with MLV-based vectors. The plasmids encoding these vectors that were constructed previously also contained an IRES and egfp for restriction analysis (Bishop et al., 2001) . The green fluorescence of GFP was not desirable for some of the immunofluorescence studies. It was removed from the vectors by deleting the SalI-NotI fragment, filling the recessed ends with Klenow enzyme followed by re-ligation of the vector.
Source of antibodies and chemicals
The rabbit anti-Fv1 antibody had been described previously (Bishop et al., 2001) . Monoclonal antitubulin, FITCconjugated anti-rabbit IgG, FITC, and TRITC-conjugated anti-mouse IgG were purchased from Sigma. Goat antivimentin, rhodamine-conjugated anti-rabbit, and FITC-conjugated anti-goat IgG were purchased from Santa Cruz Laboratories. Monoclonal anti-TGN38 was purchased from BD Transduction Laboratories. HRP-conjugated protein A was purchased from Bio-Rad. BODIPY FL C5 ceramide, BODIPY TR ceramide, Alexa Fluor 488-conjugated Concanavalin A, Lucifer yellow, MitoTracker red, Alexa Fluor 350-conjugated anti-rabbit IgG, and the Pacific blue labelled Tyramide system amplification kit were purchased from Molecular Probes.
Cells and viruses
All cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum and antibiotics. Viruses were produced using the transient three-plasmid expression system as described previously (Bock et al., 2000; Soneoka et al., 1995) . Briefly, plasmids providing env, gag/gag-pol, and vector, respectively, were introduced into 293T cells using the calcium phosphate transfection method. Seventeen hours posttransfection the cells were treated with 10 mM sodium butyrate in DMEM for 8 h. The virus-containing supernatant was harvested 12 h after sodium butyrate treatment and passed through a 0.45-m filter before storage at Ϫ70°C.
Restriction assay
Restriction assays were performed as previously described (Bock et al., 2000) . Briefly, cells were seeded in 12-well plates at a density of 2 ϫ 10 4 cells per well. The cells were then transduced with retroviral vectors carrying Fv1 and egfp. Two days posttransduction, the transduced cells were split 1 in 15 into 12-well plates and challenged with tester viruses carrying the yfp marker and containing either N-, B-, or NB-tropic capsids. FACS analysis was performed on the cells 2 days posttransduction to determine the percentage of cells expressing Fv1 that were transduced by the tester virus.
Western blot analysis
Fv1 n -transduced M. dunni cells were seeded into 6-cm dishes, while NIH3T3, BALB3T3, and M. dunni cells were seeded into 13-cm dishes and grown to confluencey. The cell monolayer was washed once with PBS and the cells were lysed with triple-detergent lysis buffer [50 mM Tris-Cl (pH 8.0) 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1% Nonidet P-40, and 0.5% sodium deoxycholate] containing complete miniprotease inhibitor cocktail (Roche) for 20 min at 4°C. Cells in the 6-cm dishes were lysed with 0.5 ml triple-detergent lysis buffer, while 1 ml lysis buffer was used for cells in 13-cm dishes. The lysate was cleared by centrifugation in a microfuge at 4°C for 10 min. The protein concentration of each lysate was determined by performing a Bradford assay (Bio-Rad). Typically, 350 g protein was loaded into each well of a 10% polyacrylamide gel for NIH3T3, BALB3T3, and M dunni cells, while 40 g protein was loaded for Fv1 n -transduced M. dunni cells. The proteins were boiled in SDS loading buffer containing 10 mM dithiothreitol and separated by polyacrylamide gel electrophoresis before transferring onto an Immobilon P membrane (Millipore) using a semidry transfer apparatus (Ancos). The membrane was blocked overnight at 4°C with 5% milk in PBS containing 1% Tween 20 (PBS-T). The anti-Fv1 antibody was diluted 1 in 100 in PBS-T containing 5% milk and added to the membrane for 1 h at room temperature. The membrane was washed four times with PBS-T containing 0.5% milk for 5 min each. HRP-conjugated protein A, diluted 1 in 1000 in PBS-T containing 5% milk, was then added to the membrane. Four more washes were performed on the membrane for 5 min each. Finally, the protein bands were detected using the enhanced chemiluminescence (ECL) system from Amersham. Quantitation of the intensity of the bands was performed using the Image Station 440CF from Kodak Digital Science.
Immunofluorescence labelling and microscopy M. dunni cells were seeded at a density of 2 ϫ 10 4 cells in 12-well plates. The cells were transduced with retroviral vectors carrying Fv1 or its various mutants the next day. Two days posttransduction, the cells were split 1 in 15 onto 13-mm coverslips in 12-well plates. The following day, the cells were washed once with PBS and fixed with 4% paraformaldehyde in PBS for 15 min at room temperature. They were then permeabilized with 0.2% Triton X in PBS for 15 min at room temperature except for detection of TGN38, when the cells were permeabilized with ice-cold methanol at Ϫ20°C for 15 min. The permeabilized cells were washed once with PBS and blocked for 20 min at room temperature with PBS containing 1% BSA. Primary antibodies were then added to the cells at the appropriate dilutions in PBS containing 1% BSA. Rabbit anti-Fv1 and monoclonal antitubulin were used at dilutions of 1:200, while goat antivimentin and monoclonal anti-TGN38 were used at dilutions of 1:100 and 1:50, respectively. The cells were incubated with the primary antibody for 1 h at room temperature before washing three times with PBS containing 1% BSA. Secondary antibodies and organelle-specific fluorescent dyes were then added at the appropriate dilutions in PBS containing 1% BSA. Rhodamine-conjugated anti-rabbit IgG and FITC-conjugated anti-goat IgG were used at dilutions of 1:400, while TRITC-conjugated anti-mouse IgG and FITC-conjugated anti-rabbit IgG were used at dilutions of 1:200. FITC-conjugated anti-mouse IgG was used at dilu-tions of 1:128, while AlexaFluor 350-conjugated anti-rabbit IgG was used at dilutions of 1:100. TRITC-conjugated phalloidin and AlexaFluor 488-conjugated Concanavalin A were used at concentrations of 0.66 M and 5 g/ml, respectively, while BODIPY FL C 5 -ceramide and BODIPY TR-ceramide were used at 5 M. The cells were incubated with the secondary antibodies and fluorescent dyes for 40 min before washing three times with PBS for 5 min each. Finally, the coverslips were mounted in Citifluor (Agar Scientific) and sealed with nail varnish.
For detection of endogenously expressed Fv1 using the TSA system from Molecular Probes, cells were seeded onto 13-mm coverslips in 12-well plates at densities of 2 ϫ 10 4 cells per well. The cells were fixed and permeabilized as described above. They were then blocked using PBS containing 1% of blocking reagent for 1 h at room temperature. Anti-Fv1 was added at a dilution of 1:1000 in PBS containing 1% blocking reagent and incubated at room temperature for 1 h. The cells were washed three times in PBS for 5 min each. HRP-conjugated anti-rabbit IgG (Molecular Probes) was then added at a dilution of 1:100 in PBS containing 1% blocking reagent and incubated at room temperature for another hour. Three washes in PBS of 5 min each were performed at room temperature. Pacific blue-labelled tyramide reagent was then diluted 1:100 in amplification buffer containing 0.0015% hydrogen peroxide and added to the cells for 5 min at room temperature. The cells were washed three times in PBS for 5 min each at room temperature. The coverslips were then mounted in Citifluor (Agar Scientific) and sealed with nail varnish.
All microscopy was performed on an Olympus IX inverted microscope with phase contrast and DIC optics using a Photometrics CH350L liquid-cooled CCD camera with a Kodak KAF1400 sensor. A 100ϫ oil immersion objective lens was used to examine the specimens.
Disruption of cytoskeleton
M. dunni cells were transduced with Fv1 and seeded onto 13-mm coverslips as described above. Prior to fixation, the medium containing the transduced cells was replaced with prewarmed medium containing the appropriate concentrations of cytoskeleton-disrupting chemicals. Cytochalasin D (Sigma), which disrupted the actin filaments, was used at a concentration of 1 g/ml. Nocodazole (Sigma), which depolymerized microtubules, was used at 66 M. Acrylamide (BDH), which caused the collapse of intermediate filaments, was used at 10 mM. The cells were treated with the cytoskeleton-disrupting drugs for 3 h at 37°C before fixing and processing for immunofluorescence labelling as described above.
